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work, we monitored the organization and dynamics of a 34-mer peptide of the CXC chemokine receptor 1
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based approaches and surface pressure measurements. Our results show that the CXCR1 N-domain 34-mer
peptide binds vesicles of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and upon binding, the
tryptophan residues of the peptide experience motional restriction and exhibit red edge excitation shift
(REES) of 19 nm. These results are further supported by increase in fluorescence anisotropy and mean
fluorescence lifetime upon membrane binding. These results constitute one of the first reports
demonstrating membrane interaction of the N-terminal domain of CXCR1 and gain relevance in the context
of the emerging role of cellular membranes in chemokine signaling.1; DMPC, 1,2-dimyristoyl-sn-
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Chemokines (chemotactic cytokines) are a large family of small
soluble proteins (70–120 residues) and play a crucial regulatory role
in innate immunity, inflammation, host defense against infection,
embryogenesis and metastasis [1,2]. They are classified either as CC,
CXC, CX3C, or C based on the presence of conserved cysteine residues
near the N-terminus. Chemokines elicit transmembrane signaling by
activation of a subclass of G-protein coupled receptors (GPCRs).
Although the chemokine receptor family is the largest subfamily of
peptide-binding GPCRs [3], the structures of chemokine receptors are
not known. This is due to the fact that very few crystal structures of
GPCRs are available because of intrinsic difficulties of determining
membrane-embedded protein structures [4]. For this reason,
approaches based on fluorescence spectroscopy have often proved
useful in elucidating the organization, topology and orientation of
GPCRs [5].A variety of studies using chimeras and mutagenesis have shown
that the extracellular N-terminal domain of chemokine receptors
plays critical roles in determining binding affinity, receptor selectivity,
and also in regulating signaling activities [1,6]. In order to understand
the role of the N-terminal domain in ligand specificity and affinity of
CXCR1, the organization and dynamics of the CXCR1 N-domain were
earlier studied in micellar environments [7]. This study showed that
the CXCR1 N-terminal domain adopts a defined conformation
(secondary structure) in dodecylphosphocholine (DPC) micelles
suggesting that the cellular membrane may play an important role
in regulating CXCR1 function. Although micelles are used as
membrane-mimetics [8], they are limited as membrane models due
to their intrinsic curvature stress, small size and lack of appropriate
interface [9]. In this paper, we have monitored the organization and
dynamics of the CXCR1 N-domain (see Fig. 1) in the presence of
membranes by utilizing a combination of fluorescence-based mea-
surements including red edge excitation shift (REES) [10], and surface
pressure measurements.
2. Materials and methods
2.1. Materials
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 3-(N-
morpholino) propanesulfonicacid (MOPS) were obtained from Sigma
Chemical Co. (St. Louis, MO). 1,2-Dioleoyl-sn-glycero-3-phosphocho-
line (DOPC) and DPC were purchased from Avanti Polar Lipids
(Alabaster, AL). The purity of DOPC was checked by thin layer
Fig. 1. A schematic representation of the CXCR1 receptor. The N-terminal domain
(whose sequence is shown) is implicated in ligand binding and signal specificity. The
sequence of the rabbit CXCR1 N-domain is shown (the tryptophan residues are
highlighted). The construct shown lacks 10 amino acids at the N-terminal end and this
stretch of amino acids has previously been shown to be not essential for ligand binding
(see ref. [7] for more details). In this study, we have monitored the interaction of CXCR1
N-terminal domain 34-mer peptide with membranes. As a negative control, a peptide
with identical amino acid composition but with a scrambled sequence was used. See
Materials and methods for other details.
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methanol/water (65:35:5, v/v/v) andwas found to give only one spot
with a phosphate-sensitive spray and on subsequent charring [11].
Concentration of DOPC was determined by phosphate assay subse-
quent to total digestion by perchloric acid [12]. DMPC was used as an
internal standard. Water was purified through a Millipore (Bedford,
MA) Milli-Q system and used throughout. N-domain CXCR1 peptides
were synthesized as described previously [7].2.2. Methods
2.2.1. Sample preparation
In this study, we have monitored the interaction of an N-terminal
CXCR1 N-domain peptide with membranes, and as a negative control,
we have used a peptide with identical amino acid composition but
with a scrambled sequence. The sequences are shown below:
CXCR1N-domain 34mer LWTWFEDEFANATGMPPVEKDYSPSLVVTQTLNK
Scrambled peptide DVPLSTSATEGKTAWDKQVMLFTLPNEYFNVWPE
Fluorescence measurements were performed using large unila-
mellar vesicles (LUVs) of 100 nm diameter of DOPC. In general,
640 nmol of DOPC was dried under a stream of nitrogen while being
warmed gently (∼35 °C). After further drying under a high vacuum
for at least 3 h, the lipid film was hydrated (swelled) by adding 1.5 ml
of 10 mM MOPS, pH 7.4 buffer, and was vortexed for 3 min to
uniformly disperse the lipid and form homogeneous multilamellar
vesicles. LUVs of 100 nm diameter were prepared by the extrusion
technique using an Avestin Liposofast Extruder (Ottawa, Ontario,
Canada) as previously described [13]. Briefly, the multilamellar
vesicles were freeze-thawed five times using liquid nitrogen to
ensure solute equilibration between trapped and bulk solutions, and
then extruded through polycarbonate filters (pore diameter of
100 nm) mounted in the extruder fitted with Hamilton syringes
(Hamilton Company, Reno, NV). The samples were subjected to 11
passes through polycarbonate filters to give the final LUV suspension.
In order to incorporate CXCR1 peptides (34-mer and scrambled) intomembranes, a small aliquot containing 1.28 nmol of the peptide from
a stock solution in water was added to the preformed vesicles and
mixed well to give membranes containing 0.2 mol% peptide. Back-
ground samples were prepared the same way except that peptides
were not added to them. Sampleswere kept in the dark for 12 h before
measuring fluorescence. All experiments were performed with
multiple sets of samples at room temperature (∼23 °C).
2.2.2. Steady state fluorescence measurements
Steady state fluorescence measurements were performed with a
Hitachi F-4010 spectrofluorometer using 1 cm pathlength quartz
cuvettes. Excitation and emission slits with a nominal bandpass of
5 nm were used for all measurements. All spectra were recorded in
the correct spectrum mode. Background intensities of samples were
subtracted from each sample spectrum to cancel out any contribution
due to the solvent Raman peak and other scattering artifacts. The
spectral shifts obtained with different sets of samples were identical
in most cases. In other cases, the values were within ±1 nm of the
ones reported. Fluorescence anisotropy measurements were per-
formed at room temperature (∼23 °C) using a Hitachi polarization
accessory. Anisotropy values were calculated from the equation [14]:
r =
IVV−GIVH
IVV + 2GIVH
ð1Þ
where IVV and IVH are the measured fluorescence intensities (after
appropriate background subtraction) with the excitation polarizer
oriented vertically and the emission polarizer vertically and horizon-
tally oriented, respectively. G is the grating correction factor that
corrects for wavelength-dependent distortion of the polarizers and is
the ratio of the efficiencies of the detection system for vertically and
horizontally polarized light, and is equal to IHV/IHH. All experiments
were done with multiple sets of samples and average values of
anisotropy are shown in Fig. 5.
2.2.3. Surface pressure measurements
Monolayer studies were performed at room temperature (∼23 °C)
using a Langmuir–Blodgett equipment (NIMA technology, Model
611MC, Coventry, U.K.), with a computer-controlled multi-compart-
ment surface area (dimensions 15cm×10 cm) with twomechanically
coupled barriers. Mili-Q water was used as the subphase and the total
volume of the subphase was 75 ml. DOPC was deposited from a
methanol stock solution on the subphase. Methanol was allowed to
evaporate and the monolayer was continuously compressed with
symmetrical barriers at a constant speed of 30 cm2/min up to its
collapse pressure. Peptides were introduced into the subphase with a
syringe after forming the lipid monolayer at an initial surface pressure
of 15 mN/m. The subphase was continuously stirred. Surface pressure
was monitored by the Wilhelmy method using a paper plate in
conjunction with a microbalance. In order to monitor the interaction
of CXCR1 peptides with DOPC monolayers, increase in surface
pressure as a function of time was monitored using NIMA software
for a given initial pressure at constant area.
2.2.4. Time-resolved fluorescence measurements
Fluorescence lifetimes were calculated from time-resolved fluo-
rescence intensity decays using IBH 5000F coaxial nanosecond flash
lamp equipment (Horiba Jobin Yvon, Edison, NJ) with DataStation
software in the time-correlated single photon counting mode. This
machine uses a thyratron-gated nanosecond flash lamp filled with
nitrogen as the plasma gas (∼1 bar) and is run at 40 kHz. Lamp
profiles were measured at the excitation wavelength using Ludox
(colloidal silica) as the scatterer. To optimize the signal to noise ratio,
5000 photon counts were collected in the peak channel. All
experiments were performed using excitation and emission slits
with a bandpass of 8 nm. The sample and the scatterer were
Fig. 2. (a) Fluorescence emission spectra of the CXCR1 N-domain and scrambled
peptides: the CXCR1 N-domain in buffer (_______, black) and DOPC vesicles (————,
blue); scrambled peptide in buffer (–– - ––, cyan) and DOPC vesicles (–– - - ––, purple).
The scrambled peptide refers to a peptide with identical amino acid composition but
with scrambled sequence (see text for details). Spectra are intensity-normalized at the
respective emission maxima. Measurements were carried out at room temperature
(∼23 °C). The excitation wavelength used was 280 nm. The ratio of peptide to lipid was
1:500 (mol/mol) and lipid concentration was 0.43 mM in all cases. (b) Binding of the
CXCR1 N-domain (●) and scrambled peptide (○) to DOPC vesicles measured by the
changes in peptide fluorescence. The ratio of fluorescence intensity monitored at 344
and 350 nm is plotted as function of lipid/peptide ratio. The concentration of peptide
was 0.85 μM in all cases. See Materials and methods for other details.
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shape and timing drifts occurring during the period of data collection.
This arrangement also prevents any prolonged exposure of the sample
to the excitation beam, thereby avoiding any possible photodamage of
the fluorophore. Data were stored and analyzed using DAS 6.2
software (Horiba Jobin Yvon). Fluorescence intensity decay curves so
obtained were deconvoluted with the instrument response function
and analyzed as a sum of exponential terms:
F tð Þ =∑iαi exp −t = τið Þ ð2Þ
where F(t) is the fluorescence intensity at time t and αi is a pre-
exponential factor representing the fractional contribution to the
time-resolved decay of the component with a lifetime τi such that
Σiαi=1. The program also includes statistical and plotting subroutine
packages [15]. The goodness of the fit of a given set of observed data
and the chosen function was evaluated by the χ2 ratio, the weighted
residuals [16], and the autocorrelation function of the weighted
residuals [17]. A fit was considered acceptable when plots of the
weighted residuals and the autocorrelation function showed random
deviation about zero with a minimum χ2 value not more than 1.4.
Intensity-averaged mean lifetimes bτN for biexponential decays of
fluorescence were calculated from the decay times and pre-exponen-
tial factors using the following equation [14]:
τ =
α1τ
2
1 + α2τ
2
2
α1τ1 + α2τ2
: ð3Þ
3. Results and discussion
3.1. Fluorescence characteristics and membrane binding of the CXCR1
N-terminal domain peptide
It is now well established that chemokine binding and function
involves two regions of the ligand and two regions of the receptors —
interactions between chemokine N-loop and receptor N-domain
residues (site-I), and between chemokine N-terminal and receptor
extracellular/transmembrane residues (site-II). The site-I interaction
plays multiple roles and mediates binding affinity and receptor
selectivity, and regulates signaling functions [1,6]. In this work, we
have used fluorescence-based approaches to probe membrane interac-
tions of a CXCR1 N-terminal domain 34-mer peptide. The fluorescence
emission spectra of the CXCR1 N-domain peptide (sequence shown in
Fig. 1) in buffer and when bound to DOPC vesicles are shown in Fig. 2a.
As a negative control, a scrambled peptide with identical amino acid
composition was used (sequences of both peptides are shown in
Materials andmethods). The scrambled sequencewasgeneratedusing a
random sequence generator from the web tool: http://www.expasy.
ch/tools/randseq.html. In addition,wemanually checked to ensure that
there was no overlap with the native sequence and that there were no
clusters of hydrophobic or charged amino acids.
The maximum of fluorescence emission3 of the tryptophan
residues in the CXCR1 N-domain peptide in buffer is 350 nm. In the
presence of DOPC vesicles, the CXCR1 N-domain peptide exhibits a
blue shifted (i.e., toward shorter wavelength) emission maximum at
344 nm, indicating a less polar environment around the tryptophan
residues, due to binding of the peptide to membranes. On the other
hand, the scrambled peptide did not show any change in the
wavelength of maximum fluorescence emission in the presence of3 We have used the term maximum of fluorescence emission in a somewhat wider
sense here. In every case, we have monitored the wavelength corresponding to
maximum fluorescence intensity, as well as the center of the mass of the fluorescence
emission. In most cases, both these methods yielded the same wavelength. In cases
where minor discrepancies were found, the center of mass of emission has been
reported as the fluorescence maximum.DOPC vesicles, thereby indicating lack of appreciable binding to
membranes.
The membrane binding of the CXCR1 N-domain peptide can be
quantitated by the blue shift of emission maximum (from 350 to
344 nm) upon binding to DOPC vesicles and can be attributed to the
change in polarity of the surrounding environment. The increase in
the fluorescence intensity ratio (F344/F350) therefore represents the
fraction of membrane-bound peptide. Fig. 2b shows the binding curve
for the CXCR1 N-domain peptide to DOPC vesicles monitored in this
fashion. The fluorescence intensity ratio gradually increases with
increasing with lipid/peptide ratio (mol/mol) and reaches a maxi-
mum value at lipid/peptide ratio of ∼500. Importantly, the fluores-
cence intensity ratio remains invariant in case of the scrambled
peptide, indicating that membrane binding of the N-terminal domain
is sequence-specific and not dependent on the overall hydrophobicity.
We chose conditions for our experiments to ensure that the CXCR1 N-
domain peptide is predominantly membrane-bound, i.e., there is no
ground state heterogeneity.
3.2. Monolayer studies with the CXCR1 N-domain peptide
In order tomonitor the interaction of the CXCR1 N-domain peptide
with membranes, we explored the interaction of the peptide with
DOPC monolayer. The monolayer technique represents a useful
Fig. 4. Effect of changing excitation wavelength on the wavelength of maximum
emission for the CXCR1 N-domain peptide in DOPC vesicles. The ratio of peptide to lipid
was 1:500 (mol/mol) and lipid concentration was 0.43 mM. The line joining the data
points is provided merely as a viewing guide. See Materials and methods for other
details.
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peptides into lipid monolayers can be studied by monitoring the
increase in surface pressure at a constant area as a function of time.
Fig. 3 shows the increase in surface pressure of DOPC monolayer with
time when the CXCR1 N-domain peptide was injected in the sub
phase. The increase in surface pressure with time is indicative of
specific binding of the CXCR1 N-domain peptide to DOPC monolayer.
In contrast, the increase in surface pressure is much less pronounced
for the scrambled peptide.
3.3. Red edge excitation shift (REES) of membrane-bound CXCR1
N-domain peptide
REES represents a powerful approach that can be used to directly
monitor the environment and dynamics around a fluorophore in
complex biological systems [10,20,21]. A shift in the wavelength of
maximum fluorescence emission toward higher wavelengths, caused
by a shift in the excitation wavelength toward the red edge of the
absorption band, is termed REES. This effect is mostly observed with
polar fluorophores in motionally restricted environments where the
dipolar relaxation time for the solvent shell around a fluorophore is
comparable to or longer than its fluorescence lifetime. We have
previously shown that REES serves as a sensitive tool to monitor the
organization and dynamics of membrane-bound peptides [22].
The shift in the maximum of fluorescence emission of the
tryptophans of the CXCR1 N-domain peptide bound to DOPC vesicles
as a function of excitation wavelength is shown in Fig. 4. As the
excitation wavelength is changed from 280 to 307 nm, the emission
maximum of membrane-bound CXCR1 N-domain peptide is shifted
from 344 to 363 nm that corresponds to REES of 19 nm. It is possible
that there could be further red shift if excitation is carried out beyond
310 nm. We found it difficult to work in this wavelength range due to
low signal to noise ratio and artifacts due to the solvent Raman peak
that sometimes remained even after background subtraction. Such
dependence of the emission maximum on excitation wavelength is
characteristic of REES. This implies that the tryptophan residues in the
CXCR1 N-domain peptide are localized in a motionally restricted
region of the membrane. It is worth mentioning here that the
magnitude of REES obtained in the case of membrane-bound CXCR1
N-domain peptide is considerably higher than what is usually
reported formembrane-bound tryptophan residues [22–24], although
higher REES has been reported in a few cases [25,26]. In a controlFig. 3. Interaction of the CXCR1 N-domain and scrambled peptides with DOPC
monolayer. The initial surface pressure was ∼15 mN/m. Change in surface pressure
with time was recorded. The gray and black lines represent the increase in surface
pressure for the CXCR1 N-domain and the scrambled peptide, respectively. Measure-
ments were carried out with 16 nmol lipid at room temperature (∼23 °C). See Materials
and methods for other details.experiment, we observed that the CXCR1 N-domain peptide exhibits a
nominal REES of 9 nm in buffer (relative to 19 nm in case of
membrane-bound peptide; see Fig. S1 in Supplementary material).
The scrambled peptide, on the other hand, displays similar REES in
buffer and in the presence of DOPC vesicles (Fig. S1 in Supplementary
material). In DPC micelles, the CXCR1 N-domain peptide shows REES
of 13 nm (see Fig. S2a in Supplementary material). The reduced
magnitude of REES could be due to curvature stress or lack of proper
interface in micelles as described above.
We interpret this restriction in tryptophan environment to the
binding of the CXCR1 N-domain peptide to DOPC membranes. The
membrane interface is characterized by unique motional and
dielectric characteristics, distinct from the bulk aqueous phase and
the more isotropic hydrocarbon-like deeper regions of the membrane
[10]. This specific region of the membrane exhibits slow rates of
solvent relaxation and is also known to participate in intermolecular
charge interactions and hydrogen bonding through the polar head-
group. These structural features, which slow down the rate of solvent
reorientation, have previously been recognized as typical features of
microenvironments giving rise to significant REES effects. It is
therefore the membrane interface that is most likely to display red
edge effects.
3.4. Fluorescence anisotropy and lifetime of the CXCR1 N-domain peptide
The steady state fluorescence anisotropy of tryptophans of the
CXCR1 N-domain peptide in buffer and DOPC vesicles are shown in
Fig. 5. As shown in the figure, the anisotropy of the CXCR1 N-domain
peptide exhibits an increase in the presence of DOPC vesicles. This
increase in anisotropy could be interpreted as the reduction in
rotational mobility of tryptophans due to binding of the peptide to
DOPC membranes. The increase in anisotropy reinforces the motion-
ally restricted environment experienced by the tryptophans upon
binding to membranes. The fluorescence anisotropy of the CXCR1 N-
domain peptide in DPC micelles is shown in Fig. S2b (see
Supplementary material).Table 1
Fluorescence lifetimes of the CXCR1 N-domain peptidea.
Condition α1 τ1 (ns) α2 τ2 (ns)
Buffer 0.69 1.11 0.31 3.74
DOPC vesicles 0.56 1.04 0.44 5.21
a The excitation wavelength was 295 nm; emission was monitored at 350 and
344 nm in buffer and DOPC vesicles, respectively. All other conditions are as in Fig. 2.
See Materials and methods for other details.
Fig. 5. Steady state fluorescence anisotropy of the CXCR1 N-domain peptide in buffer
and DOPC vesicles. The excitation wavelength used was 295 nm. Emission was
monitored at 350 and 344 nm in case of buffer and DOPC vesicles, respectively. Data
shown are means±S.E. of at least three independent measurements. All other
conditions are as in Fig. 2. See Materials and methods for other details.
Fig. 6. (a) Representative time-resolved fluorescence intensity decay of the CXCR1 N-
domain peptide in buffer. The excitation wavelength was 295 nmwhich corresponds to
a peak in the spectral output of the nitrogen lamp. Emission was monitored at 350 nm.
The sharp peak on the left is the lamp profile. The relatively broad peak on the right
is the decay profile, fitted to a biexponential function. The two lower plots show
the weighted residuals and the autocorrelation function of the weighted residuals.
(b) Mean fluorescence lifetime of the CXCR1 N-domain peptide in buffer and DOPC
membranes. The excitation wavelength was 295 nm. Emission was monitored at 350
and 344 nm in case of buffer and DOPC vesicles, respectively. Mean fluorescence lifetimes
were calculated from Table 1 using Eq. (3). Measurements were carried out at room
temperature (∼23 °C). Data shown are means±S.E. of at least three independent
measurements. All other conditions are as in Fig. 2. See Materials and methods for other
details.
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environment in which a given fluorophore is placed [27]. In general,
tryptophan lifetimes are known to be reduced when exposed to polar
environments [28]. A typical decay profile of the CXCR1 N-domain
peptide in buffer with its biexponential fitting and the statistical
parameters used to check the goodness of the fit is shown in Fig. 6a.
Table 1 shows the tryptophan lifetimes for the CXCR1 N-domain
peptide in buffer and DOPC vesicles. All fluorescence decays could be
fitted with a biexponential function. We chose to use the intensity-
averaged mean fluorescence lifetime as an important parameter since
it is independent of the method of analysis and the number of
exponentials used to fit the time-resolved fluorescence decay. The
mean fluorescence lifetime was calculated using Eq. (3). Fig. 6b shows
that the mean fluorescence lifetime of tryptophans in the CXCR1 N-
domain peptide in buffer is ∼2.7 ns. The lifetime increases to ∼4.4 ns
in the presence of DOPC vesicles. The increase in mean fluorescence
lifetime could be due to the reduced polarity experienced by the
CXCR1 N-domain tryptophans upon binding to DOPC membranes
[28]. Interestingly, the mean fluorescence lifetime of the CXCR1 N-
domain peptide in DPC micelles is somewhat shorter, possibly due to
increased water penetration (see Fig. S2c in Supplementary material).
Chemokine receptors belong to the GPCR superfamily of receptors.
The GPCR superfamily is the largest andmost diverse protein family in
mammals, involved in signal transduction across membranes [29].
GPCRs mediate multiple physiological processes such as neurotrans-
mission, cellular metabolism, secretion, cellular differentiation,
growth, inflammatory and immune responses. For this reason,
GPCRs have emerged as major targets for the development of novel
drug candidates in all clinical areas [30]. Yet, exploring structure–
function relationships of GPCRs poses considerable challenge since
very few crystal structures of GPCRs are available [4]. This is due to the
inherent difficulty in crystallizing membrane proteins in their native
conditions because of their intrinsic dependence on surrounding
membrane lipids [31]. In this overall context, monitoring organization
of the functionally important domains, such as illustrated in this study
for a chemokine receptor N-terminal domain peptide and its
interaction with membranes using fluorescence-based approaches
assume relevance.
In this paper, we explored the organization and dynamics of the
CXCR1 N-terminal domain in the membrane milieu. Our results,
utilizing intrinsic fluorescence of tryptophans and monolayer studies,
show that the CXCR1 N-domain preferentially interacts with
membranes. To the best of our knowledge, this is the very first report
showing interaction of functionally important N-terminal domain of
any chemokine receptor with membrane bilayers. We report that
upon binding tomembranes, the tryptophan residues of the CXCR1 N-domain experience motional restriction and exhibit REES. This is
further supported by increase in fluorescence anisotropy and mean
fluorescence lifetime upon membrane binding. This motional restric-
tion could result in loss of conformational entropy and therefore likely
to influence ligand binding properties of the receptor. These results
assume significance in view of the role of chemokine receptors in a
number of inflammatory diseases and cancer [3,32], and the emerging
paradigm that cellular membranes could be important modulators of
chemokine receptors.
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